Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients

American Journal of Hematology

Volumn 81, Issue 7, 2006, Pages 484-491

  Mazzella, Fermina M ^a,g   Smith, David ^a   Horn, Paul ^b   Cotelingam, James D ^c   Rector, James T ^d   Shrit, M Atef ^e   Pesce, Amadeo ^f   Schumacher, Harold R ^f  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e MIAMI VALLEY HOSPITAL   (United States)

^f UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^g UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Blast; Erythroid hyperplasia; Erythroleukemia; Myelodysplastic syndrome; Pronormoblast

Indexed keywords

ADULT; AGED; ARTICLE; CELL SURVIVAL; CORRELATION ANALYSIS; ERYTHROBLAST; ERYTHROCYTE MEMBRANE; ERYTHROLEUKEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MYELOBLAST; MYELODYSPLASIA; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STATISTICAL MODEL; THROMBOCYTE COUNT;

AGE FACTORS; DISEASE-FREE SURVIVAL; ERYTHROBLASTS; ERYTHROCYTE COUNT; ERYTHROCYTES; GRANULOCYTE PRECURSOR CELLS; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33745713106     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20563     Document Type: Article

References (25)

1. DiGuglielmo G. Le malatte eritremiche ed eritroleucemiche. Rome, II Pensiero Scientifico, 1962.
2. Benedetti G. L'eritremia cronica (considerazioni su di un caso tipico di miclosi aneritremica eronica). Haematologica 1938;229-263.
3. Heilmeyer L, Schoener W. Die chronische reine erythroblastose des erwachsenen als leukaemie-parallerer prozess des erythrocytaeren systems. Deutsch Arch Klin Med 1941;3-4.
4. Pontoni L. Le eritremic eroniche. Riform Med 1942;15.
5. Carere-Comes O, Del Dotto M. Sulla mielosi eritremica eronica dell'adulto (Malattia di DiGuglielmo). Settim Med 1945;9-17.
6. DiGuglielmo G. Les maladies erythremicques. Rev Hemat 1946;1:355-398.
7. Finkel HE, Brauer MJ. Giant eosinophilic granules in the chronic DiGuglielmo syndrome. New Engl J Med 1966;274:4; 209-210.
8. Bindi M, Quartieri F, Siuti E, Stefanelli A, Mechelli S, Castiglioni MG. Mielosi eritremica eronica (o forma cronica della malattia di Di Guglielmo). Descrizione di un caso. Rec Prog Med 1999;90:4;213-215.
9. Brunning RD, Bennett JM, Flandrin G, Matutes E, Head D, Vardiman JW, Harris NL. Myelodysplastic syndromes: introduction, Cha 3, World Health Organization Classification of Tumors: tumors of hematopoietic and lymphoid tissues. IARC Press, Washington, DC, 2001. p 64.
10. Mazzella FM, Kowal-Vern A, Shrit MA, Wibowo AL, Rector JT, Cotelingam JD, Collier J, Mikhael A, Cualing H, Schumacher HR. Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics and prognosis. Am J Clin Patol 1998;10:5;590-598.
11. Foucar K. Hematopoiesis, Ch 1, Bone marrow pathology. ASCP Press, Chicago, 1995. p 6.
12. Bull BS, Breton-Gorius J, Beutler E. Morphology of the erythron, Ch 30, in Hematology, Williams W, Beutler B, Erslev AJ, Lichtman MA, eds. McGraw-Hill, New York, 1990. p 299.
13. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-2088.
14. Lawless JF. Statistical models and methods for lifetime data. Wiley, New York, 1982. p 580.
15. StataCorp, Stata Statistical Software: Release 8.0, Stata Press, College Station, TX. 2003.
16. Brunning RD, Matutes E, Flandrin G, Vardiman J, Bennett J, Head D, Harris NL. Acute myeloid leukemias, Ch 4, World Health Organization Classification of Tumors: tumors of hematopoietic and lymphoid tissues. IARC Press, Washington, DC. 2001. p 97.
17. Mazzella FM, Tolbert D, Kowal-Vern A, Shrit MA, Rector JT, Cotelingam JD, Schumacher HR. p53 gene mutation in acute erythroleukemia: differences between subtypes M6a, M6b and M6c. Lab Hem 1999;5:1;28-36.
18. Mazzella FM, Kowal-Vern A, Shrit MA, Rector JT, Cotelingam JD, Schumacher HR. Effects of multi-drug resistance gene expression in acute erythroleukemia. Mod Pathol 2000;13:4; 407-413.
19. Mazzella FM, Alvares C, Kowal-Vern A, Schumacher HR. The acute erythroleukemias. Clin Lab Med Acute Leukemias 2000;20:1;119-137.
20. Mufti GJ, Galton DA. Myelodysplastic syndromes: natural history and features of prognostic importance. Clin Hem 1986;15:4;953-971.
21. Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 2000;24:12;983-992.
22. Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res 2004;28:6;587-594.
23. Aul C, Giagounidis A, Germing U, Ganser A. Evaluating the prognosis of patients with myelodysplastic syndromes. Ann Hem 2002;81:485-497.
24. Campioni D, Punturieri M, Bardi A, Moretti S, Tammiso E, Lanza F, Castoldi G. In vitro evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach. Leuk Res 2004;28:9-17.
25. Zhu J, Emerson SG. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002;21:3295-3313.